Identification of sitagliptin binding proteins by affinity purification mass spectrometry: Sitagliptin binding proteins identified by affinity purification mass spectrometry

Type 2 diabetes mellitus (T2DM) is recognized as a serious public health concern with increasing incidence. The dipeptidyl peptidase-4 (DPP-4) inhibitor sitagliptin has been used for the treatment of T2DM worldwide. Although sitagliptin has excellent therapeutic outcome, adverse effects are observed...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Xue-Ning, Sim, Byu-Ri, Chen, Hong, Zheng, Yun-Xiao, Xue, Jun-Biao, Wang, Lei, Kong, Wei-Sha, Zhou, Kuan, Guo, Shu-Juan, Hou, Jing-Li, Zhang, Jiong, Jiang, He-Wei, Tao, Sheng-Ce
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9827809/
https://www.ncbi.nlm.nih.gov/pubmed/36239351
http://dx.doi.org/10.3724/abbs.2022142